NSEAnalysts/Institutional Investor Meet/Con. Call Updates23 Jun 2026 · 23 Jun 2026, 06:16 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Alivus Life Sciences Limited · ALIVUS
✦ AI Summary▲ Positive
Alivus Life Sciences Limited announced that institutional investors are scheduled to visit its plant in Ankleshwar, Gujarat, on June 29, 2026. This will be an in-person, group or one-on-one meeting. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Such interactions facilitate greater transparency and engagement with the investment community, allowing investors to gain direct insights into the company's operations and facilities.
Analysis Scores
Earnings Impact3/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
GLS_23062026181545_BSE_NSE_Investor_Meet_Signed.pdf
View document text
June 23, 2026
To, To,
Dy. General Manager The Manager – Listing,
Department of Corporate Services, National Stock Exchange of India Ltd.,
BSE Ltd., Plot No. C/1, G Block,
P. J. Towers, Dalal Street, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS
Dear Sirs,
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015 – Intimation of Institutional Investor Meeting – Plant Visit
With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of
Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would
like to inform that few Institutional Investors will be visiting the Company’s Plant as follows:
Date Particulars Mode Place Type of Meeting
June 29, 2026 Plant Visit for In-Person Ankleshwar, Gujarat Group/One on One
Institutional Investors
The schedule and mode of meeting may undergo a change due to exigencies on part of the
Investor/Company.
You are requested to kindly take a note of the same.
Thanking You,
Yours Sincerely,
For Alivus Life Sciences Limited
(formerly Glenmark Life Sciences Limited)
Rudalf Corriea
Company Secretary & Compliance Officer
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited)
Corporate Office: Registered Office:
Technopolis Knowledge Park, A wingO, ffice No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate
4th Floor, Mahakali Caves Road, Andheri E(), Mumbai– 400093 Mohol Bazarpeth, Solapur 413 213, India
T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com